DAWN - Day One Biopharmaceuticals, Inc.

QQQ $ 608.50 $ 0.46 (0.08 %)

DIA $ 471.86 $ -2.94 (-0.62 %)

SPY $ 671.77 $ -0.11 (-0.02 %)

TLT $ 88.93 $ -0.51 (-0.57 %)

GLD $ 375.82 $ -6.91 (-1.8 %)

Previous Close

$ 8.85

Open

$ 8.75

Bid

$ 8.77 x 208

Ask

$ 8.79 x 506

Day's Range

$ 8.56 - $ 9.05

52 Week Range

$ 5.64 - $ 15.05

Volume

3,549,459

Average Volume

Market Cap

908.68M

Beta (5Y Monthly)

$ 0.15

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-05-2025	06-30-2025	10-Q
3	05-06-2025	03-31-2025	10-Q
4	02-25-2025	12-31-2024	10-K
5	10-30-2024	09-30-2024	10-Q
6	08-02-2024	06-30-2024	10-Q
7	05-06-2024	03-31-2024	10-Q
8	02-26-2024	12-31-2023	10-K
9	11-06-2023	09-30-2023	10-Q
10	08-07-2023	06-30-2023	10-Q
11	05-01-2023	03-31-2023	10-Q
12	03-06-2023	12-31-2022	10-K
13	11-07-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-12-2022	03-31-2022	10-Q
16	03-07-2022	12-31-2021	10-K
17	11-08-2021	09-30-2021	10-Q
18	08-10-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

day-one-biopharma-expands-oncology-pipeline-with-285-million-mersana-buyout

Day One Biopharma Expands Oncology Pipelin...
11/13/2025 15:15:16

Day One Biopharmaceuticals plans to acquire Mersana Therapeutics in a deal worth up to $285 million to expand its cancer drug p...

Day One Biopharmaceuticals Agrees To Acqui...
11/13/2025 11:05:07

Under the terms of the definitive merger agreement, Day One will promptly commence a tender offer to acquire all of the outstan...

Day One Biopharmaceutical Announced It Wil...
11/10/2025 12:13:18

JP Morgan Maintains Overweight on Day One ...
11/07/2025 19:42:58

JP Morgan analyst Anupam Rama maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Overweight and raises the price targe...

12 Health Care Stocks Moving In Wednesday'...
11/05/2025 17:05:53

Piper Sandler Maintains Overweight on Day ...
11/05/2025 15:44:09

Piper Sandler analyst Kelsey Goodwin maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Overweight and raises the pric...

Day One Biopharmaceutical Q3 EPS $(0.19) B...
11/04/2025 21:01:05

Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

super-micro-computer-posts-downbeat-q4-results-joins-personalis-snap-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Super Micro Computer Posts Downbeat Q4 Res...
08/06/2025 12:11:55

HC Wainwright & Co. Maintains Buy on Day O...
08/06/2025 11:24:39

HC Wainwright & Co. analyst Andrew S. Fein maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the p...

Needham Maintains Buy on Day One Biopharma...
08/06/2025 09:39:05

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target from $18 ...

why-astera-labs-shares-are-trading-higher-by-over-17-here-are-20-stocks-moving-premarket

Why Astera Labs Shares Are Trading Higher ...
08/06/2025 09:35:31

12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 21:07:20

Day One Biopharmaceutical Q2 EPS $(0.29) B...
08/05/2025 20:01:12

Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimat...

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

Needham Maintains Buy on Day One Biopharma...
05/07/2025 12:19:17

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target from $30 ...

Day One Biopharmaceutical Q1 EPS $(0.35) B...
05/06/2025 20:04:54

Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimat...

Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

HC Wainwright & Co. Reiterates Buy on Day ...
04/03/2025 10:43:21

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains...

Goldman Sachs Maintains Buy on Day One Bio...
03/25/2025 15:38:11

Goldman Sachs analyst Andrea Tan maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target fr...